| [1] |
Yang Q, Qu L, Tian H, et al. Prevalence and characteristics of psoriatic arthritis in Chinese patients with psoriasis[J]. J Eur Acad Dermatol Venereol, 2011,25(12):1409⁃1414. doi: 10.1111/j.1468⁃3083.2011.03985.x.
|
| [2] |
Zhang H, Chen M, Cui R, et al. Prevalence of psoriatic arthritis in Chinese population with psoriasis: a multicenter study conducted by experienced rheumatologists[J]. Chin Med J (Engl), 2023,136(12):1439⁃1447. doi: 10.1097/CM9.00000000 00002683.
|
| [3] |
《中国关节病型银屑病诊疗共识(2020)》编写委员会专家组. 中国关节病型银屑病诊疗共识(2020)[J]. 中华皮肤科杂志, 2020,53(8):585⁃595. doi: 10.35541/cjd.20200369.
|
| [4] |
Wang ZZ, Wang HS. The role of osteoclasts in psoriatic arthritis[J]. Int J Dermatol Venerol, 2021, 4(4): 242⁃247. doi:10.1097/jd9.0000000000000141.
|
| [5] |
Wang Y, Xiao Y, Li F, et al. The clinical characteristics of psoriatic arthritis: a cross⁃sectional study based on the psoriatic arthritis Cohort of West China Hospital[J]. Rheumatol Ther, 2023,10(3):775⁃784. doi: 10.1007/s40744⁃023⁃00537⁃1.
|
| [6] |
Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study[J]. Arthritis Rheum, 2006,54(8):2665⁃2673. doi: 10.1002/art.21972.
|
| [7] |
Consultation WE. Appropriate body⁃mass index for Asian populations and its implications for policy and intervention strategies[J]. Lancet, 2004,363(9403):157⁃163. doi: 10.1016/S0140⁃6736(03)15268⁃3.
|
| [8] |
Gottlieb AB, Merola JF. Axial psoriatic arthritis: an update for dermatologists[J]. J Am Acad Dermatol, 2021,84(1):92⁃101. doi: 10.1016/j.jaad.2020.05.089.
|
| [9] |
Song Z, Deng X, Xie W, et al. Clinical characteristics of psoriatic arthritis in Chinese patients: a cross⁃sectional study[J]. Rheumatol Ther, 2021,8(4):1845⁃1857. doi: 10.1007/s40744⁃021⁃00384⁃y.
|
| [10] |
He S, Yang F, Lu C, et al. Sex⁃specific differences in patients with psoriatic arthritis:a nationwide study from the Chinese Registry of Psoriatic Arthritis (CREPAR IV)[J]. Clin Rheumatol, 2024,43(3):1063⁃1071. doi: 10.1007/s10067⁃023⁃06859⁃3.
|
| [11] |
徐丽玲, 邹燕, 李玉慧, 等. 银屑病关节炎伴发疾病的临床特征分析[J]. 中华风湿病学杂志, 2023,27(3):164⁃170. doi: 10.3760/cma.j.cn141217⁃20220721⁃00314.
|
| [12] |
Zhao SS, Pittam B, Harrison NL, et al. Diagnostic delay in axial spondyloarthritis: a systematic review and meta⁃analysis[J]. Rheumatology (Oxford), 2021,60(4):1620⁃1628. doi: 10.1093/rheumatology/keaa807.
|
| [13] |
Kılıç G, Kılıç E, Tekeoğlu İ, et al. Diagnostic delay in psoriatic arthritis: insights from a nationwide multicenter study[J]. Rheumatol Int, 2024,44(6):1051⁃1059. doi: 10.1007/s00296⁃023⁃05479⁃z.
|
| [14] |
Ogdie A, Nowell WB, Applegate E, et al. Patient perspectives on the pathway to psoriatic arthritis diagnosis: results from a web⁃based survey of patients in the United States[J]. BMC Rheumatol, 2020,4:2. doi: 10.1186/s41927⁃019⁃0102⁃7.
|
| [15] |
Zhou H, Qiu L, Sun P, et al. Clinical joints manifestations in patients with psoriatic arthritis on musculoskeletal ultrasound[J]. Clin Rheumatol, 2022,41(4):1211⁃1218. doi: 10.1007/s10067⁃021⁃05974⁃3.
|
| [16] |
López⁃Medina C, Molto A, Sieper J, et al. Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross⁃sectional ASAS⁃PerSpA study[J]. RMD Open, 2021,7(1):e001450. doi: 10.1136/rmdopen⁃2020⁃001450.
|
| [17] |
Lu C, Yang F, Liu H, et al. Chinese Registry of Psoriatic Arthritis (CREPAR): I. Clinical characteristics of Chinese patients with psoriatic arthritis[J]. Int J Rheum Dis, 2023,26(9):1737⁃1744. doi: 10.1111/1756⁃185X.14805.
|
| [18] |
Ohara Y, Kishimoto M, Takizawa N, et al. Prevalence and clinical characteristics of psoriatic arthritis in Japan[J]. J Rheumatol, 2015,42(8):1439⁃1442. doi: 10.3899/jrheum.141598.
|
| [19] |
Shin D, Kim HJ, Kim DS, et al. Clinical features of psoriatic arthritis in Korean patients with psoriasis: a cross⁃sectional observational study of 196 patients with psoriasis using psoriatic arthritis screening questionnaires[J]. Rheumatol Int, 2016,36(2):207⁃212. doi: 10.1007/s00296⁃015⁃3365⁃3.
|
| [20] |
Feld J, Chandran V, Haroon N, et al. Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison[J]. Nat Rev Rheumatol, 2018,14(6):363⁃371. doi: 10.1038/s41584⁃018⁃0006⁃8.
|
| [21] |
Pennington SR, FitzGerald O. Early origins of psoriatic arthritis: clinical, genetic and molecular biomarkers of progression from psoriasis to psoriatic arthritis[J]. Front Med (Lausanne), 2021,8:723944. doi: 10.3389/fmed.2021.723944.
|
| [22] |
Jin Y, Cheng IT, So H, et al. Utility of multi⁃biomarker panel on discriminating disease activity in patients with psoriatic arthritis[J]. Int Immunopharmacol, 2024,143(Pt 1):113279. doi: 10. 1016/j.intimp.2024.113279.
|
| [23] |
Zabotti A, De Marco G, Gossec L, et al. EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis[J]. Ann Rheum Dis, 2023,82(9):1162⁃1170. doi: 10.1136/ard⁃2023⁃224148.
|
| [24] |
Patience A, Steultjens M, Siebert S, et al. Significant functional impairment and disability in individuals with psoriatic arthritis and Achilles tendon pain: a cross⁃sectional observational study[J]. Rheumatol Int, 2024,44(8):1469⁃1479. doi: 10.1007/s00296⁃024⁃05629⁃x.
|
| [25] |
Yamada Y, Inui K, Okano T, et al. Ultrasound assessment, unlike clinical assessment, reflects enthesitis in patients with psoriatic arthritis[J]. Clin Exp Rheumatol, 2021,39(1):139⁃145. doi: 10.55563/clinexprheumatol/u8qc6c.
|
| [26] |
Bonfiglioli KR, Lopes F, Figueiredo LQ, et al. Ultrasonographic insights into peripheral psoriatic arthritis: updates in diagnosis and monitoring[J]. J Pers Med, 2024,14(6):550. doi: 10.3390/jpm14060550.
|
| [27] |
Song Z, Geng Y, Zhang X, et al. Subclinical dactylitis is linked with active phenotype of psoriatic arthritis[J]. Joint Bone Spine, 2025,92(1):105784. doi: 10.1016/j.jbspin.2024.105784.
|
| [28] |
Li B, Su R, Yan H, et al. Immunological risk factors for nonalcoholic fatty liver disease in patients with psoriatic arthritis: new predictive nomograms and natural killer cells[J]. Front Immunol, 2022,13:907729. doi: 10.3389/fimmu.2022.907729.
|
| [29] |
Wang Y, Ding L, Chen J, et al. Risk factors for progression from subclinical to clinical phase of psoriatic arthritis: a case⁃control study[J]. Rheumatol Ther, 2021,8(1):585⁃597. doi: 10.1007/s40744⁃021⁃00295⁃y.
|
| [30] |
Kumthekar A, Ogdie A. Obesity and psoriatic arthritis: a narrative review[J]. Rheumatol Ther, 2020,7(3):447⁃456. doi: 10.1007/s40744⁃020⁃00215⁃6.
|